Biotech News

Scholar Rock to Report Third Quarter 2026 Financial Results on November 10, 2026

Scholar Rock (SRRK)Scholar RockEarnings

CAMBRIDGE, Mass. --(BUSINESS WIRE)--Oct. 20, 2026-- Scholar Rock (NASDAQ: SRRK) today announced that it will report third quarter 2026 financial results on Tuesday, November 10, 2026, before the financial markets open. The Company will host a conference call and webcast with Scholar Rock management

Related news

Scholar Rock

Myostatin Biology Scholar Rock develops therapies that selectively modulate growth factors in their latent forms. Its lead work targets myostatin to improve muscle function while preserving related signaling pathways. Apitegromab Apitegromab is a selective inhibitor of latent myostatin under FDA review for children and adults with spinal...

Recent company news

Stock data

Close
50.37 USD
Market cap
5.35B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States